Home › Trial NCT04599686
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer
- Trial IDNCT04599686
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorChanghai Hospital
- Enrollment100
- Start date2022-09-11
- ConditionsTreatment
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.